Rid­ing on wave of clin­i­cal tri­al re­forms, ma­chine learn­ing start­up bags $50M to cre­ate 'dig­i­tal twin­s'

As drug de­vel­op­ers and reg­u­la­tors alike in­creas­ing­ly warm to cre­ative ideas for run­ning clin­i­cal tri­als, a ma­chine learn­ing plat­form cre­at­ed by three physi­cists is draw­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER